HMGB1 |
Exosome |
Esophageal squamous cell carcinoma cell lines |
Cell culture medium |
(65) |
Exosome |
Hepatocellular carcinoma cell lines |
Cell culture medium |
(66) |
Exosome |
Lewis lung carcinoma (LLC) cell lines and mice model |
Cell culture medium and blood |
(67) |
Exosome |
Glioma cells |
Cell culture medium |
(69) |
HSP60, HSP70 and HSP90 |
Exosome |
HepG2 hepatocellular carcinoma cells |
Cell culture medium |
(83) |
HSP70 |
Exosome |
Melanoma |
|
(84) |
HSP60 and HSP70 |
Exosome |
NCI-H292 (human mucoepidermoid bronchial carcinoma), A549 (human lung adenocarcinoma) and K562 (human erythroleukemia) cell lines |
Cell culture medium |
(88) |
HSP90 |
Extracellular vesicles |
Bladder cancer cell lines |
Cell culture medium |
(90) |
HSP90α |
Exosome |
Breast cancer cell lines |
Cell culture medium |
(92) |
Alpha crystalline and HSP22 |
Exosome |
Gynecological cancers |
Serum |
(89) |
S100A9 |
Exosome |
Chronic lymphocytic leukemia |
Plasma |
(100) |
S100A9 |
Exosome |
Polycystic ovary syndrome |
Follicular fluid |
(101) |
S100A7A |
Exosome |
LIM1863 colon carcinoma cell-derived organoids |
Cell culture medium |
(62) |
S100A5 |
Microvesicle |
Colorectal cancer cells |
Cell culture medium |
(103) |
S100A12 |
Extracellular Vesicles |
Brain cancer cells, colorectal cancer cells, melanoma cells, kidney cancer cells |
Cell culture medium |
(59) |
S100A4 |
Extracellular vesicles |
Bladder cancer cell lines and bladder cancer patients |
Cell culture medium and urine |
(90) |